I believe in taking a holistic approach to caring for patients. Their courage and resilience, in the face of life-threatening illness, has been one of the major influences on my growth as an individual and a professional. I try to empower patients by providing them information about their illness so they can truly become partners in their own healthcare.
The James has genuine culture of patient-centered care. Everyone pulls through to provide care for patients, and for each other as well. It often feels like working among friends and family, and I’m privileged to serve alongside such outstanding professionals.
Recently I assumed leadership of the multidisciplinary cutaneous lymphoma program. This program is unique for the high level of vertical (bench to bedside) as well as horizontal (multispecialty) integration. I’m honored to lead such an eminent program that was developed by my colleague, Dr. Pierluigi Porcu, an internationally renowned expert in cutaneous lymphomas.
Ain Shams University, Faculty of Medicine
University of Pittsburgh Medical Center
7/1/2003 - 7/31/2005
Ain Shams University Hospitals
5/1/1998 - 5/31/2001
Additional languages I speak
Specialties and conditions I treat
Locations where I practice
More about my work
The New York Hospital Cornell Medical Center
7/1/2008 - 8/8/2008
University of Nebraska Medical Center
7/1/2009 - 6/30/2012
American Board of Internal Medicine
American Board of Internal Medicine (Subspecialty: Hematology)
American Board of Internal Medicine (Subspecialty: Hospice and Palliative Medicine)
American Board of Internal Medicine (Subspecialty: Medicine Oncology)
News about me
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. William has reported no financial relationships with medical device, research and/or drug companies.